Axsome Therapeutics, Inc.
(NASDAQ : AXSM)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Other
symbolcompany%chnglast%shortavg$volume
SAVACassava Sciences, Inc. -0.78%77.990.0%$189.33m
VRXValeant Pharmaceuticals International, Inc. -2.08%29.1714.1%$171.64m
HZNPHorizon Therapeutics Plc -1.14%91.095.5%$141.83m
JAZZJazz Pharmaceuticals Plc -1.26%175.512.2%$114.55m
ICLRICON plc -1.99%213.294.2%$101.79m
CTLTCatalent, Inc. -2.03%108.322.1%$97.46m
SAGESAGE Therapeutics, Inc. 1.38%55.937.6%$65.73m
UTHRUnited Therapeutics Corp. -1.77%179.1814.0%$65.23m
ARGXargenx SE 0.43%316.250.0%$63.95m
BHCBausch Health Cos., Inc. -2.08%29.170.0%$59.95m
PRGOPerrigo Co. Plc -0.96%47.246.9%$54.34m
PCRXPacira Biosciences, Inc. -2.01%59.249.9%$27.12m
AXSMAxsome Therapeutics, Inc. -0.81%66.001.9%$22.00m
RVMDRevolution Medicines, Inc. -2.76%33.100.0%$21.97m
IRWDIronwood Pharmaceuticals, Inc. 0.13%11.499.6%$20.62m

Company Profile

Axsome Therapeutics, Inc. engages in the development of novel therapies for the management of central nervous system disorders. Its product candidates include AXS-05, AXS-07, AXS-12, and AXS-14 which are being developed for multiple pain and primary care indications. The company was founded by Herriot Tabuteau on January 12, 2012 and is headquartered in New York, NY.